The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Symptom clusters in patients with advanced cancer in an early-phase clinical trials clinic.
 
Goldy George
No Relationships to Disclose
 
Eucharia Chiege Iwuanyanwu
No Relationships to Disclose
 
Alizeh Yusuf
No Relationships to Disclose
 
Karen O Anderson
No Relationships to Disclose
 
Sarina Anne Piha-Paul
Research Funding - Abbvie; Bayer; Biomarin; Cerulean Pharma; Curis; Five Prime Therapeutics; GlaxoSmithKline; Helix BioPharma; Incyte; Merck; Novartis; Puma Biotechnology; Samumed; XuanZhu
 
Aung Naing
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; Baxter (I); EMD Serono; Healios; Incyte; Karyopharm Therapeutics; MedImmune; NCI; Novartis; Regeneron
Travel, Accommodations, Expenses - ARMO BioSciences
 
Filip Janku
Consulting or Advisory Role - Deciphera; Foundation Medicine; Novartis; Sequenom; Trovagene
Research Funding - Agios; Astellas Pharma; Biocartis; BioMed Valley Discoveries; Deciphera; Foundation Medicine; Novartis; Roche; Trovagene
Other Relationship - Bio-Rad
 
Vivek Subbiah
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); BioXCell (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche/Genentech (Inst)
 
Xin Shelley Wang
No Relationships to Disclose
 
Qiuling Shi
Consulting or Advisory Role - Amgen
Research Funding - Bayer; Bristol-Myers Squibb
 
Tito R. Mendoza
Consulting or Advisory Role - Amgen
Research Funding - Bayer; Bristol-Myers Squibb; Genentech
 
David S. Hong
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Genentech; Lilly; Merck; Mirati Therapeutics; miRNA Therapeutics; Novartis; Pfizer
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
 
Charles S. Cleeland
Honoraria - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Merck Sharp & Dohme; Novartis; Onconova Therapeutics; Pfizer
Research Funding - Bayer (Inst); Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Bayer License agreement to use the MDASI (M D Anderson Symptom Inventory) (Inst)
Travel, Accommodations, Expenses - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer